Plain-English translation of NCT06629428 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a medication called to see if it helps people with relapsing multiple sclerosis (a type of MS where symptoms come and go) walk better and stay balanced. Researchers will measure how the medication affects your walking, your ability to recover from slips, and your thinking and memory over 12 months of treatment.
Doctors believe this medication works well for MS, but they want to understand specifically how it helps people move and stay steady on their feet. This research could help doctors recommend this treatment earlier and improve how people with MS live their daily lives.
You likely qualify if…
You likely don't qualify if…
You will receive the medication as infusions over 48 weeks (about 11 months). You'll visit the clinic at the start, halfway through, and at the end for walking tests, balance assessments (including safe slip tests on a treadmill while wearing a safety harness), and cognitive tests. Researchers will also check your disease progression through blood tests and neurological exams.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States